Hovione, a provider of spray drying and particle engineering, has expanded its continuous manufacturing offering and services with a new state-of-the-art continuous manufacturing facility coming online at its Loures site in Portugal. Also, to support providing access and services for continuous tableting, Hovione has further strengthened its capabilities by establishing a highly experienced multi-disciplinary global team in continuous tableting and upgrading its labs with the tools needed to support the drug product lifecycle from research & development to commercial production.
 
Continuous manufacturing is expected to change the landscape of drug product development and commercial production. The FDA is partnering with the International Council for Harmonization and leading a global initiative to advance continuous manufacturing of small molecules and other pharmaceutical modalities.
 
Hovione is offering customers a commercial continuous tableting platform prepared to support key control needs and deliver on operational excellence, mechanistic modeling, and appropriate process analytical technology (PAT). Additionally, Hovione´s quality system has been designed to support the release of continuous tableting products through automated in-process controls, deployment of real time release, and compliant digital infrastructure.
 
According to the company, this technology offers a distinct set of features and advantages including faster development of simpler processes, agile manufacturing for variable demand, robust control strategies and high process quality standards. 
 
“Hovione has been historically focused on innovative technologies that benefit our customers and patients. With this investment in continuous tableting, our customers can rely on our support to bring much needed medicines to the market as fast as possible with the highest quality and manufacturing standards.”, comments Jean-Luc Herbeaux, Hovione´s CEO. “We are investing to accelerate the adoption of this technology as we continue to innovate and enhance our offering around our areas of expertise.”